MerckMRK

Merck's Keytruda and vaccine franchises lean on bioprocessing and fill-finish partners.

View stock

Theme · Biopharma manufacturing

Where the cash goes~$30B / yr · FY2025

R&D$17B

Dividends$8B

Capex$5B

Money flows left → right · hover a node · click to open the stock.ManufacturingComponents

Most exposed to MRK's spend

Thermo FisherTMOCurated
Bioprocessing and CDMO.
Manufacturing
DanaherDHRCurated
Bioprocessing and filtration.
Manufacturing
West PharmaceuticalWSTCurated
Vial and injectable components.
Components
CatalentCTLTCurated
Fill-finish capacity.
Manufacturing

Relationships are hand-curated and sourced from filings, announcements, and public reporting — a map for generating ideas, not a complete supply chain, and not investment advice. Exposure weights are relative, for sizing only. Spot something missing? Contributions welcome on GitHub.